<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02375906</url>
  </required_header>
  <id_info>
    <org_study_id>HepNet-HDIN</org_study_id>
    <nct_id>NCT02375906</nct_id>
  </id_info>
  <brief_title>The Hepatitis Delta International Network</brief_title>
  <acronym>HDIN</acronym>
  <official_title>Hepatitis Delta Registry and Research Network- Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HepNet Study House, German Liverfoundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Center for Infection Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HepNet Study House, German Liverfoundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatitis delta is a major health problem, not only because of the severity of the disease,
      but also due to the lack of effective antiviral treatment. To improve the current therapeutic
      options, a better understanding of the pathophysiology is essential. Reliable research in
      this direction is only possible with large patient study groups. However, given the
      geographic distribution of hepatitis delta, larger patient cohorts would only be possible
      through multicenter collaboration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hepatitis international network cohort is a multicenter, observational study that will
      build up a research registry of HDV patients all over the world.

      The aims of this project are:

      i. Collect clinical information from hepatitis delta patients from multiple centers
      distributed worldwide in order to build up a large database that will enable and facilitate
      further research on chronic hepatitis delta.

      ii. To better inform patients about their viral infection, present status and evolution of
      liver disease throughout time. To give them the tools needed to inform other peers and
      medical professionals about the significance and consequences of a chronic hepatitis delta
      infection.

      iii. To allow the participating physicians to track course of the disease, therapies, signs
      and symptoms of the hepatitis delta patients included by their center.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Proportion of chronic hepatitis B patients with chronic hepatitis D infection worldwide</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HDV-RNA HBsAg</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HBV-DNA</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of treated chronic hepatitis B patients with chronic hepatitis D infection worldwide</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Hepatitis D</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic hepatitis delta will be screened regardless of HDV or HBV genotype
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Positive HBs antigen and antiHDV for longer than 6 months.

        Exclusion Criteria:

        Absence of any cause of relevant liver disease other than HDV (i.e. hemochromatosis,
        autoimmune hepatitis, alcoholic or toxic liver disease, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael P Manns, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heiner Wedemeyer, Prof.Dr.</last_name>
    <email>Wedemeyer.Heiner@mh-hannover.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Svenja Hardtke, Dr.</last_name>
    <email>Hardtke.Svenja@mh-hannover.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna; Internal Med.III</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Ferenci, Prof. dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Swoboda</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fundacao de Medicina Tropical</name>
      <address>
        <city>Manaus</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wornei S Braga</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Pesquisa em Medicina Tropical</name>
      <address>
        <city>Rondonia</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Miguel Villalobos Salcedo</last_name>
    </contact>
    <contact_backup>
      <last_name>Lourdes M Bozacov</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical Center Mrcheveli</name>
      <address>
        <city>Tiflis</city>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Metreveli, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Irakli Rtskhiladze, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medizinisches Infektiologiezentrum</name>
      <address>
        <city>Berlin</city>
        <zip>10439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Ingiliz, Dr.med.</last_name>
    </contact>
    <investigator>
      <last_name>A Baumgarten, Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik I Charite- Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marion Muche, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Christina Grunow</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heiner Wedemeyer, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dep.of Medicine University of Thessalony</name>
      <address>
        <city>Larissa</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg N Dalekos, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Zachoo Kalliopi, Dr.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Casa Sollievo della Sofferenza Hospital</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Grazia A Niro, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept.of Medicine Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saeed Hamid, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverstomach Clinic</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaigham Abbas, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sverdlovsk Reginal Hepatologial Center</name>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Bessanova</last_name>
    </contact>
    <contact_backup>
      <last_name>Tatiana Tobolina</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Vall dÂ´Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Buti, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Maria Homs</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ankara University; Faculty of Medicine</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cihan Yurdaydin</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Brazil</country>
    <country>Georgia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Pakistan</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>August 25, 2017</last_update_submitted>
  <last_update_submitted_qc>August 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HDV, hepatitis delta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis D</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

